PD Dr. Michael Hoffmeister

PD Dr. Michael Hoffmeister

PD Dr. Michael Hoffmeister

Funktion:

Stellvertretender Abteilungsleiter, Gruppenleiter

Telefonnr.:

+49 (0)6221 42-1303

Fax:

+49 (0)6221 42-1302

Gebäude:

Im Neuenheimer Feld 581

Raum:

S 1.200

Stellvertretender Abteilungsleiter
Gruppenleiter "Molekular-pathologische Epidemiologie"

Forschungsschwerpunkte

Darmkrebsprävention
Screening
Risikofaktoren und prognostische Faktoren
Molekular-pathologische Epidemiologie

 

Wissenschaftliche Studien, Projekte, Aktivitäten

DACHS-Studie, Principal Investigator (seit 2011)
IMPACT Konsortium, Netzwerkkoordinator (seit 2009), Co-Principal Investigator
KolosSal-Studie, Co-Principal Investigator (seit 2009)
SAMS-Studie, Co-Principal Investigator (seit 2012)
GECCO Consortium (Seattle, USA), Co-Investigator (seit 2009)
RAPS-Studie, Co-Investigator (seit 2014)
DARIO-Studie, Co-Investigator (seit 2015)

Gewähltes Mitglied des Wissenschaftlichen Rats des DKFZ (seit 2015)

 

Aktuelle Gruppenmitglieder MPE

Elizabeth Alwers, MD
Efrat Amitay, PhD
Prudence Carr, PhD
Margherita D'Errico, MSc

Ehemalige Gruppenmitglieder MPE

Stefanie Bienert, MSc
Min Jia, PhD

 

Publikationen

Artikel in PubMed 

 

Ausgewählte Publikationen

Screening

Hoffmeister M, Holleczek B, Stock C, Zwink N, Stolz T, Stegmaier C, Brenner H. Utilization and determinants of follow-up colonoscopies within 6 years after screening colonoscopy: prospective cohort study. Int J Cancer 2019;144(2):402-10

Lauby-Secretan B, Vilahur N, Bianchini F, Guha N, Straif K; International Agency for Research on Cancer Handbook Working Group. The IARC Perspective on Colorectal Cancer Screening. N Engl J Med 2018;378(18):1734-40

Hoffmeister M, Holleczek B, Zwink N, Stock C, Stegmaier C, Brenner H. Screening for Bowel Cancer: Increasing Participation via Personal Invitation. Dtsch Arztebl Int 2017;114(6):87-93

Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014;348:g2467

Brenner H, Chang-Claude J, Jansen L, Knebel P, Stock C, Hoffmeister M. Reduced risk of colorectal cancer up to 10 y after screening, surveillance, or diagnostic colonoscopy. Gastroenterology 2014;146(3);709-17

Risikofaktoren und prognostische Factoren
Carr PR, Weigl K, Jansen L, Walter V, Erben V, Chang-Claude J, Brenner H, Hoffmeister M. Healthy Lifestyle Factors Associated With Lower Risk of Colorectal Cancer Irrespective of Genetic Risk. Gastroenterology 2018;155(6):1805-15


Carr PR, Banbury B, Berndt SI, Campbell PT, Chang-Claude J, Hayes RB, Howard BV, Jansen L, Jacobs E, Lane DS, Nishihara R, Ogino S, Phipps AI, Slattery ML, Stefanick ML, Wallace R, Walter V, White E, Wu K, Peters U, Chan AT, Newcomb PA, Brenner H, Hoffmeister M. Association Between Intake of Red and Processed Meat and Survival in Patients With Colorectal Cancer in a Pooled Analysis. Clin Gastroenterol Hepatol 2018, doi: 10.1016/j.cgh.2018.11.036. [Epub ahead of print]

Hoffmeister M, Jansen L, Rudolph A, Toth C, Kloor M, Roth W, Bläker H, Chang-Claude J, Brenner H. Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustment. J Natl Cancer Inst 2015;107(6):djv045

Carr PR, Walter V, Brenner H, Hoffmeister M. Meat subtypes and their association with colorectal cancer: systematic review and meta-analysis. Int J Cancer 2015;138(2):293-302

Molekular-pathologische Epidemiologie
Jia M, Zhang Y, Jansen L, Walter V, Edelmann D, Gündert M, Tagscherer KE, Roth W, Bewerunge-Hudler M, Herpel E, Kloor M, Ulrich A, Burwinkel B, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. A prognostic CpG score derived from epigenome-wide profiling of tumor tissue was independently associated with colorectal cancer survival. Clin Epigenetics 2019;11(1):109.

Kather JN, Pearson AT, Halama N, Jäger D, Krause J, Loosen SH, Marx A, Boor P, Tacke F, Neumann UP, Grabsch HI, Yoshikawa T, Brenner H, Chang-Claude J, Hoffmeister M, Trautwein C, Luedde T. Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer. Nat Med 2019;25(7):1054-56

Amitay EL, Carr PR, Jansen L, Walter V, Roth W, Herpel E, Kloor M, Bläker H, Chang-Claude J, Brenner H, Hoffmeister M. Association of Aspirin and Nonsteroidal Anti-Inflammatory Drugs With Colorectal Cancer Risk by Molecular Subtypes. J Natl Cancer Inst 2019;111(5):475-83

Alwers E, Jia M, Kloor M, Bläker H, Brenner H, Hoffmeister M. Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review. Clin Gastroenterol Hepatol 2019;17(3):402-10

Bläker H*, Alwers E*, Arnold A, Herpel E, Tagscherer KE, Roth W, Jansen L, Walter V, Kloor M, Chang-Claude J, Brenner H, Hoffmeister M. The Association Between Mutations in BRAF and Colorectal Cancer-Specific Survival Depends on Microsatellite Status and Tumor Stage. Clin Gastroenterol Hepatol 2019;17(3):455-62 (*equal contribution)

Carr PR*, Alwers E*, Bienert S, Weberpals J, Kloor M, Brenner H, Hoffmeister M. Lifestyle factors and risk of sporadic colorectal cancer by microsatellite instability status: a systematic review and meta-analyses. Ann Oncol 2018;29(4):825-34 (*equal contribution)

 

nach oben
powered by webEdition CMS